FDA proposes that doctors learn about acupuncture for pain management

Share these links with your doctor or that skeptical family member. Acupuncture is a viable alternative therapy recommended by the FDA as an alternative to Opioid prescription medications.  We have extensive clinical experience successfully treating pain with acupuncture, allowing patients to either reduce or eliminate pain medication quickly by getting the patient pain free.

 

“The guidelines now recommend that doctors get information about chiropractic care and acupuncture as therapies that might help patients avoid prescription Opioids.   ….the American College of Physicians recommended non-surgical treatments such as acupuncture, yoga, and chiropractic care as the first options for treating lower back pain.”

 

In this article, the FDA Proposes Doctors Learn About Acupuncture for Pain Management:

https://www-pbs-org.cdn.ampproject.org/c/s/www.pbs.org/newshour/amp/health/fda-proposes-doctors-learn-acupuncture-pain-management

 

A follow-up to this article: the FDA has approved changes to its blueprint for health providers to include recommending acupuncture as an alternative to pain medication. 

See page 3 in the link below for specific mention about acupuncture, 

“II. NONPHARMACOLOGIC THERAPIES
A number of nonpharmacologic therapies are available that can play an important role in
managing pain, particularly musculoskeletal pain and chronic pain.
• Psychological approaches – e.g., cognitive behavioral therapy
• Physical rehabilitative approaches – e.g., physical therapy, occupational therapy
• Surgical approaches
• Complementary therapies – e.g., acupuncture, chiropracty
HCPs should be knowledgeable about the range of available therapies, when they may be
helpful, and when they should be used as part of a multidisciplinary approach to pain
management.”

https://www.fda.gov/downloads/Drugs/NewsEvents/UCM557071.pdf

This article was posted in Uncategorized. Bookmark the permalink. Follow comments with the RSS feed for this post. Both comments and trackbacks are closed.